Previous studies have documented lower expression of RASSF1α in non-small cell lung cancer, esophageal squamous cell carcinoma and lacrimal gland carcinoma (Zeng et al., 2015[17]). This evidence concerns the gene RASSF1 and esophageal squamous cell carcinoma.